Treatment for Aneurysm

Waitlist Available · 18+ · All Sexes · Kiel, Germany

This study is evaluating whether a stent can be used to treat aneurysms.

See full description

About the trial for Aneurysm

Eligible Conditions
Intracranial Aneurysm · Aneurysm

Treatment Groups

This trial involves a single treatment. Treatment is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.

Main TreatmentA portion of participants receive this new treatment to see if it outperforms the control.
Control TreatmentAnother portion of participants receive the standard treatment to act as a baseline.


This trial is for patients born any sex aged 18 and older. There are 6 eligibility criteria to participate in this trial as listed below.

Inclusion & Exclusion Checklist
Mark “yes” if the following statements are true for you:
Patient has the necessary mental capacity to participate and is willing and able to participate in the study for the duration of the study follow-up and is able to comply with study requirements
Patient able to able to give their informed consent can be included in this study. This must be demonstrated by means of a personally signed and dated informed consent document indicating that the subject has been informed of and understood all pertinent aspects of the study.
Patients who are suitable for non-emergency endovascular embolization of saccular IAs
Patient's indication for treatment of unruptured IAs according to the national/international guidelines.
Age 18-80 years at screening
IA located at a bifurcation in the anterior or posterior circulation with dimensions consistent with implant size selection guidelines included in the IFU
View All
Odds of Eligibility
Be sure to apply to 2-3 other trials, as you have a low likelihood of qualifying for this one.Apply To This Trial
Similar Trials

Approximate Timelines

Please note that timelines for treatment and screening will vary by patient
Screening: ~3 weeks
Treatment: varies
Reporting: 6 months
Screening: ~3 weeks
Treatment: Varies
Reporting: 6 months
This trial has approximate timelines as follows: 3 weeks for initial screening, variable treatment timelines, and reporting: 6 months.
View detailed reporting requirements
Trial Expert
Connect with the researchersHop on a 15 minute call & ask questions about:
- What options you have available- The pros & cons of this trial
- Whether you're likely to qualify- What the enrollment process looks like

Measurement Requirements

This trial is evaluating whether Treatment will improve 2 primary outcomes in patients with Aneurysm. Measurement will happen over the course of From day 31 to 6 months after treatment.

The proportion of subjects with death of any non-accidental cause or any major disabling stroke after treatment or major disabling stroke or death due to neurological cause.
The occlusion rate as adjudicated by a core laboratory.
Success will be defined as complete occlusion demonstrated by a Grade 1 using the Raymond Roy Scale.

Patient Q & A Section

Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What causes aneurysm?

Atherectomy is a viable option in the face of a wide variety of disorders and lesions in the abdominal aorta. We suggest that pre-and post-operatively, careful surveillance should be done in patients with aneurysms due to other causes.

Anonymous Patient Answer

What are the signs of aneurysm?

Some signs of aneurysm are sudden headache, visual disturbances, loss of vision, nausea, dizziness and loss of consciousness. In the presence of multiple symptoms it is important to remember that there is a possibility that the symptoms may be due to a head injury. These symptoms should be noted and brought to the attention of the patient's doctor for further diagnostic evaluation.

Anonymous Patient Answer

What are common treatments for aneurysm?

The most common treatment for aneurysms is medication, including medications to slow or restrict smooth muscle cell proliferation. The other treatments used for aneurysms range from surgical techniques to mechanical devices. Of the treatments, most are used when the aneurysm is expected to pose a significant threat to the patient's life. There are many less common treatment options that can be used to treat aneurysms. They are used with the hope of minimizing the risk to the patient.

Anonymous Patient Answer

What is aneurysm?

An aneurysm manifests as a dilation that occurs in any part of a blood vessel wall. For an aneurysm to progress to become an aneurysmal, large, and/or persistent dilation, a rupture of the aneurysmal wall and haematoma can occur, a breakdown between the layers of the wall of the blood vessel, and may result in massive bleeding into the surrounding body tissue that may have a drastic effect on the function, health and even the life of the person who may have the aneurysm.

Anonymous Patient Answer

How many people get aneurysm a year in the United States?

The annual number of ruptured AAA patients is increasing. Over the lifetime of an average person the disease can develop in 4.3% of cases. Most patients are older than 70 years of age. The prevalence of ruptured abdominal aortic aneurysms is 2% in Caucasians and 6% in Africans. The epidemiological features of ruptured AAA vary from country to country, and have significant economic consequences.

Anonymous Patient Answer

Can aneurysm be cured?

If an aneurysm were ruptured, or if the aneurysm were removed quickly, there would be nearly complete restoration of normal vascular flow, and a low rate of recurrence, even over time. In these patients, aneurysms have almost never been cured. However if the aneurysm ruptures for a second time, there is no likelihood of complete restoration of blood flow. As with any other blood disorder, the best treatment remains to be determined and the chance of cure is still quite small.

Anonymous Patient Answer

Does treatment improve quality of life for those with aneurysm?

In one exploratory study, in this population at risk for elective AAA repair, treatment with a surgical aneurysm exclusion device reduced both the incidence and severity of postoperative chronic dysaesthesia after the operation. The improvement in dysaesthesia after treatment is a novel, important and promising dimension of treatment efficacy that merits further investigation.

Anonymous Patient Answer

What are the latest developments in treatment for therapeutic use?

The latest research in the field of therapeutic revascularization of the peripheral artery system has progressed steadily over a period of 25 consecutive years. It now includes both surgical and endovascular revascularization and an increasing number of non-surgical therapeutic options.

Anonymous Patient Answer

What is the average age someone gets aneurysm?

It is not common to find an average age for the time people are diagnosed with a ruptured aneurysm, although those diagnosed between the ages of 10 and 60 are common. There is no good reason to believe the average age at which people are diagnosed is different from that of those aged 40 to 60 years or younger.\n

Anonymous Patient Answer

How does treatment work?

The [transjugular embolization procedure for treating giant aneurysms of the abdominal aorta]] decreases the risk of rupture and increases the life expectancy of the patients.[].

Anonymous Patient Answer

What does treatment usually treat?

The commonality between the treatment recommendations provided in treatment manuals is not a coincidence, as these treatments are seen as the standard-of-care treatments for a variety of ailments. Although not all of the physicians in the sample were aware of current standards of care, their decisions reflected the belief that treatment is a treatment.

Anonymous Patient Answer
See if you qualify for this trial
Get access to this novel treatment for Aneurysm by sharing your contact details with the study coordinator.